If progressive COPD noncandidate for endoscopic surgical LVRS w BODE Index 5 6 PCO2 50 mmHg and or PaO2

By rray, 22 February, 2024
Detail (Long)
If progressive COPD, noncandidate for endoscopic/surgical LVRS, w/ <a href=https://www.nejm.org/doi/pdf/10.1056/NEJMoa021322><u>BODE Index</u></a> 5-6, PCO<sub>2</sub> >50 mmHg and/or PaO<sub>2</sub> <60 mmHg, and FEV<sub>1</sub> <25% predicted, refer for <b>lung txp eval</b>. Txp improves functional capacity, QOL in select pts w/ very severe COPD (FEV<sub>1</sub> <30% predicted) [C]. Txp-list criteria (any 1 of): BODE >7, FEV<sub>1</sub> <15%-20% predicted, ≥3 exac/past yr, severe exac w/ hypercapnic resp failure, mod/severe pulm HTN.